Location History:
- Osaka, JP (2008 - 2013)
- Kanagawa, JP (2017 - 2020)
Company Filing History:
Years Active: 2008-2020
Title: Nobuyuki Negoro: Innovator in Pharmaceutical Compounds
Introduction
Nobuyuki Negoro is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target Toll-like receptor 4 (TLR4) signaling pathways. With a total of 12 patents to his name, Negoro's work has the potential to impact the treatment of various diseases.
Latest Patents
Negoro's latest patents include innovative cyclic compounds that exhibit superior TLR4 signaling inhibitory action. One notable compound is ethyl 6-((2-chloro-4-fluorobenzyl)sulfonyl)-3-hydroxycyclohex-1-ene-1-carboxylate, which may serve as a prophylactic or therapeutic drug for autoimmune diseases, inflammatory diseases, chemotherapy-induced peripheral neuropathy (CIPN), chemotherapy-induced neuropathic pain (CINP), liver failure, and ischemia reperfusion injury (IRI). These compounds are designed to be effective in treating inflammatory diseases and central nervous system disorders.
Career Highlights
Nobuyuki Negoro is currently associated with Takeda Pharmaceutical Company Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in therapeutic settings, particularly in addressing complex medical conditions.
Collaborations
Negoro has collaborated with notable colleagues, including Tsuneo Yasuma and Toshitake Kobayashi. These partnerships have contributed to the advancement of his research and the successful development of innovative pharmaceutical solutions.
Conclusion
Nobuyuki Negoro's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in the industry. His work continues to pave the way for new therapeutic options for patients suffering from various diseases.